‘The investigation of elagolix for endometriosis can be an important step in the exploration of potential remedies for this underserved patient population,’ said Rita Jain, M.D., divisional vice president, Pain, Respiratory and Metabolic Development, Global Pharmaceutical R&D, Abbott. ‘We are very happy to announce that the Phase 3 trial has begun screening for enrollment.’ Another pivotal Phase 3 research is planned with an NDA filing targeted in 2016.. Abbott commences elagolix Stage 3 trial in endometriosis Abbott , in cooperation with Neurocrine Biosciences, Inc. , today announced the initiation of a pivotal Phase 3 clinical trial made to evaluate the protection and efficacy of elagolix in female individuals with endometriosis.MRI scanning is normally sensitive and specific for acoustic tumours highly. Regular appearances of the inner ear and eighth cranial nerve on a well performed MRI scan can reliably exclude an acoustic neuroma in individuals with suspicious symptoms. For a patient with rapidly progressive symptoms and problems in obtaining a expert referral for MRI scanning, a freely available contrast improved CT scan will reasonably exclude the current presence of a big tumour with accompanying brainstem compression and hydrocephalus needing urgent treatment.